Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

NCT07743554 is registered in ClinicalTrials.gov with Girish Dhall, MD as lead sponsor.

NCT NCT07743554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07743554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor
Lead sponsor
Girish Dhall, MD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
January 31, 2032
Enrollment
23 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mpnst (malignant peripheral nerve sheath tumor)